Webinars and Sponsored Roundtables — Register Now
Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
Sciteck Diagnostics
| Company | Sciteck Diagnostics |
|---|---|
| Name of urinalysis instrument | AUA-450 Clinical Chemistry Analyzer |
| Contact | Kerstin Lanier |
| City, State | Fletcher, NC |
| Phone | 800-749-4537 |
| Website | myautoua.com |
| Type of instrument | urine chemistry |
| Instrument list price | $40,000–$45,000 (price based on location; available via purchase or lease) |
| First year instrument sold in the U.S. | 2022 |
| Approximate No. of units in clinical use in the U.S./outside the U.S. | 26/2,400 (in Japan) |
| Foreign countries where company markets instrument | none |
| Country where instrument is designed/manufactured | Japan/Japan |
| Human languages (other than English) supported | Japanese |
| Intended urine sample volume per day | 50–1,000 |
| Dimensions (H×W×D) | 24 × 34 × 26 in. |
| Weight fully loaded with reagents/without reagents | 255 lbs./250 lbs. |
| Power requirements | 120 VAC |
| Mean time between failure of instrument | 0 days |
| Events that cause instrument to lock or stop analysis | user ID failure, QC failure, sampling error, consumables replacement/expiration |
| • Urine chemistry tests available on instrument in the U.S. | albumin/microalbumin (0.5–100 mg/dL), creatinine (0–1,000 mg/dL), albumin/creatinine ratio (<30 mg/g), protein/creatinine ratio (<150 mg/g), bilirubin (0–300 mg/dL), hemoglobin (0–5,000 μg/dL), glucose (0–1,000 mg/dL), ketone (0–200 mg/dL), leukocyte esterase (0–200 leukocytes/L), nitrite (0–200 mg/dL), pH (3–11), protein (0–30 mg/dL), specific gravity (1.00–1.07), urobilinogen (0–30 mg/dL) |
| • Color compensation pad included/Flagging thresholds customizable | no/yes |
| • Test strip configuration | no test strip |
| • Calibration required after each test strip lot No. change | — |
| • Frequency of customer-performed calibration/Form of calibration | daily/liquid |
| • How results are displayed for urine chemistry | true values, calculated values |
| • Specific gravity correction for protein/glucose | yes/yes |
| • Microscopy/sediment technology | — |
| • Microscopy/sediment analysis parameters | — |
| • Flagging thresholds customizable | — |
| • Instrument eliminates amorphous crystal interference before sample analysis | — |
| • How results are displayed for microscopy/sediment | — |
| • Reporting format customizable | — |
| • No. of results that can be held in internal memory | — |
| Reagent shelf life/storage temp. for unopened containers of calibrator | 720 days/8°C |
| Reagent shelf life/storage temp. for opened containers of calibrator | 30 days/8°C |
| Reagent shelf life/storage temp. for unopened containers of control reagent | 720 days/8°C |
| Reagent shelf life/storage temp. for opened containers of control reagent | 30 days/8°C |
| Reagent barcode-reading capability | yes, for all tests (can read Code 39, Code 128, more) |
| How often quality control samples are run | daily |
| Sample throughput per hour/Time to first result for chemistry | 22/13 min. |
| Sample throughput per hour/Time to first result for microscopy/sediment | — |
| Analyzer has stat mode | yes (minimum sample volume, 0.25 mL) |
| FDA approved for body fluid analysis | yes (for urine) |
| Sample dilutions required for urinalysis/body fluid analysis | no/no |
| Minimum width of sample tube/Minimum length of sample tube | 14 mm/25 mm |
| Conditions or substances that prevent a sample from being run | none |
| Means of sample ID entry | barcode scan, manual entry, worklist download from host |
| Built-in liquid-level sensing for samples | yes |
| Information that can be barcode scanned on instrument | operator identifier, specimen identifier, reagent lot No. |
| Compatible with laboratory automation systems | no |
| How LOINC codes for results are made available | e-mail query, transmitted to LIS with each result |
| Software includes reflex testing/cross-check functionality | no/no |
| Instrument automatically generates consolidated report* | no |
| Instrument archives patient data | yes |
| Instrument connections to transfer information | directly to LIS, EHR |
| Interface standards or formats supported | ASTM 1394-91, ASTM 1381, ASTM 1238-95, HL7 version 2, HL7 version 3 |
| Bidirectional interface | yes, to other companies’ LISs and EHRs (requires interface engine with LIS) |
| Test results can be transmitted to LIS as soon as tests completed | yes |
| Connection to LIS/EHR to upload patient and QC results | LIS and EHR: direct serial, hospital network |
| Information included in transmission to data-management system | device unique identifier, operator ID, patient ID, specimen ID, result, LOINC codes |
| Training included with instrument purchase | yes (2.5 days at customer or vendor site [optional]; follow-up training available for an extra charge) |
| Approximate scheduled maintenance time required | 30 min. monthly |
| Onboard diagnostics for troubleshooting | yes (can perform diagnostics via remote access) |
| Provide list of client sites to potential customers on request | yes (partial list of comparable sites but prospective client must sign a nondisclosure agreement) |
| Clients restricted from sharing their experience with company or software | no |
| Distinguishing instrument features (supplied by company) | AutoUA is an FDA-cleared quantitative urinalysis system; superior test results; sample size of 2–3 μL provides stoichiometric advantages, reducing interferents that affect test strips |